MariMed Inc.
MRMD
$0.0725
$0.00141.97%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.68% | -3.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.68% | -3.91% | |||
| Cost of Revenue | -13.22% | 10.41% | |||
| Gross Profit | 19.11% | -24.25% | |||
| SG&A Expenses | 13.67% | -7.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.89% | 3.55% | |||
| Operating Income | 41.30% | -173.58% | |||
| Income Before Tax | 20.41% | -856.76% | |||
| Income Tax Expenses | -42.78% | 655.42% | |||
| Earnings from Continuing Operations | 33.91% | -724.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -966.67% | 81.25% | |||
| Net Income | 33.54% | -711.47% | |||
| EBIT | 41.30% | -173.58% | |||
| EBITDA | 13.00% | -59.39% | |||
| EPS Basic | 33.49% | -696.30% | |||
| Normalized Basic EPS | 14.58% | -- | |||
| EPS Diluted | 33.49% | -696.30% | |||
| Normalized Diluted EPS | 14.58% | -- | |||
| Average Basic Shares Outstanding | 0.34% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||